Alcon

ALC Healthcare Medical Instruments & Supplies

Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.

Revenue
+8.74%
EPS
−100.0%
Free cash flow
−0.54%
Total debt
−0.55%

Quarter to June 2026, against a year earlier

74.75 1.80 −2.35%
Market cap
$36.9B
P/E
58.4×
Fwd P/E
44.5×
Dividend yield
0.46%
F-score
6/9
Altman Z
n/a
Beneish M
−2.56
Dividend safety
66/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — — 4 7 4 7 8 6
P/E ratio
0.00 21.68 0.00 0.00 0.00 114.02 101.44 39.11 41.41 39.60
P/S ratio
0.00 0.00 0.00 3.68 4.72 5.15 3.89 4.02 4.23 3.74
Altman Z″-Score (non-manufacturers)
8.16 — — — — — — — — —
P/FCF ratio
0.00 0.00 51.80 113.19 123.15 258.72 71.82 70.73 29.83 24.10
Beneish M-Score
— — — (3.28) (2.72) (2.64) (2.50) (2.49) (2.65) (2.56)
P/Operating CF
944.50 944.50 944.50 79.82 73.49 110.31 98.25 84.21 91.44 59.07
Dividend Safety Score
— — — — — — — — — 66
P/B ratio
1.25 1.25 1.25 1.43 1.71 2.22 1.72 1.84 1.95 1.76
EV/Sales
0.00 0.00 0.00 4.03 5.10 5.45 4.31 4.40 4.52 4.04
EV/EBITDA
0.00 0.00 0.00 23.86 30.44 25.11 21.07 18.38 16.97 16.46
EV/FCF
51.63 51.63 51.63 124.08 132.92 273.90 79.59 77.52 31.83 26.04
Current Ratio
1.81 1.85 1.80 1.84 2.21 2.18 1.90 2.35 2.77 2.12
Net Debt/EBITDA
0.07 (0.02) (0.07) 2.09 2.24 1.39 2.06 1.61 1.07 1.23
Debt/Equity
0.01 0.01 0.01 0.18 0.22 0.21 0.24 0.23 0.22 0.22
ROE
(0.71%) 1.12% (1.00%) (3.13%) (2.79%) 1.97% 1.72% 4.83% 4.83% 4.50%
ROA
(0.60%) 1.86% (0.83%) (2.40%) (1.92%) 1.35% 1.17% 3.31% 3.40% 3.17%
ROIC
0.00% 0.00% (0.69%) (0.53%) (1.41%) 1.67% 1.80% 2.68% 3.62% 3.38%
Return on Tangible Assets
(4.51%) 6.36% (5.27%) (12.99%) (8.63%) 5.68% 5.17% 12.79% 12.09% 11.99%
Average Days of Receivables
85.60 88.56 66.64 68.40 73.82 66.26 70.60 69.64 64.78 68.85
Earnings Yield
(6.67%) 4.61% (0.44%) (2.39%) (1.65%) 0.88% 0.99% 2.56% 2.41% 2.53%
Free Cash Flow Yield
0.00% 0.00% 1.93% 0.88% 0.81% 0.39% 1.39% 1.41% 3.35% 4.15%
Free Cash Flow per Share
0.00 2.50 0.88 0.50 0.54 0.34 0.96 1.09 2.85 3.27
Book value per Share
0.00 46.83 46.37 39.54 38.49 39.30 40.04 41.83 43.59 44.68
Free Cash Flow
1,202.94 1,223.47 428.00 244.00 262.00 165.00 472.00 537.00 1,407.00 1,613.00
EV/EBIT
0.00 0.00 0.00 0.00 0.00 77.92 55.90 40.06 31.69 30.88
Other line items

Show all line items

Columns are period end dates